ストックスクリーナーアプリを入手
18.06
4.80%
-0.91
前日終値:
$18.97
開ける：
$19
24時間の取引高:
1.47M
Relative Volume:
0.86
時価総額：
$1.83B
収益：
$54.55M
当期純損益:
$-193.57M
株価収益率:
-6.2491
EPS:
-2.89
ネットキャッシュフロー:
$-181.86M
1週間 パフォーマンス:
-6.42%
1か月 パフォーマンス:
+10.46%
6か月 パフォーマンス:
+45.18%
1年 パフォーマンス:
-7.43%
1日の値動き範囲:
$17.86
$19.03
1週間の範囲:
$17.86
$19.54
52週間の値動き範囲:
$8.18
$22.50
Nurix Therapeutics Inc Stock (NRIX) Company Profile
名前
Nurix Therapeutics Inc
セクター
電話
(415) 660-5320
住所
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
18.06 | 1.92B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-10-21 | 開始されました | Mizuho | Outperform |
| 2025-03-17 | 開始されました | Leerink Partners | Market Perform |
| 2024-12-10 | 開始されました | BTIG Research | Buy |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-10-11 | 開始されました | Jefferies | Buy |
| 2024-09-06 | 再開されました | Robert W. Baird | Outperform |
| 2024-07-31 | 開始されました | Truist | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2023-03-09 | 開始されました | Barclays | Overweight |
| 2023-02-28 | 開始されました | Oppenheimer | Outperform |
| 2022-10-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 開始されました | Wells Fargo | Equal Weight |
| 2021-12-29 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-14 | 開始されました | SVB Leerink | Outperform |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-30 | 再開されました | Piper Sandler | Overweight |
| 2021-04-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2020-11-19 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-18 | 開始されました | JP Morgan | Overweight |
| 2020-08-18 | 開始されました | Needham | Buy |
| 2020-08-18 | 開始されました | Piper Sandler | Overweight |
| 2020-08-18 | 開始されました | Stifel | Buy |
すべてを表示
Nurix Therapeutics Inc (NRIX) 最新ニュース
Trading Systems Reacting to (NRIX) Volatility - Stock Traders Daily
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is It Too Late to Sell Shiva Texyarn LimitedTechnical Breakout Signals & Discover Top Gainers in Every Sector - earlytimes.in
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
(NRIX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Certain Pre-funded Warrants of Nurix Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Nurix Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - marketscreener.com
Certain Stock Options of Nurix Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - marketscreener.com
Certain Common Stock of Nurix Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - marketscreener.com
Does Strong Early Waldenström Data Redraw The Bull Case For Nurix Therapeutics’ Degrader Platform (NRIX)? - Yahoo Finance
Wells Fargo Reaffirms a Buy Rating on Nurix Therapeutics (NRIX), Sets a $30 PT - Insider Monkey
Nurix Therapeutics (NRIX): Revisiting Valuation After a 120% Three-Month Share Price Surge - Yahoo Finance
Should I hold or sell Nurix Therapeutics Inc. stock in 20252025 Geopolitical Influence & AI Forecasted Stock Moves - Улправда
Stock Analysis: Is Nurix Therapeutics Inc. stock a defensive play in 2025Quarterly Performance Summary & AI Forecasted Entry and Exit Points - Улправда
12 Small Cap Stocks to Buy with Huge Upside Potential - Insider Monkey
Does New NX-5948 Phase 2 Dose Selection Change The Bull Case For Nurix Therapeutics (NRIX)? - simplywall.st
Is Nurix Therapeutics Inc. stock a defensive play in 2025Index Update & Stepwise Entry/Exit Trade Alerts - Улправда
Will Nurix Therapeutics Inc. stock gain from lower inflationEarnings Trend Report & Reliable Price Breakout Alerts - Улправда
Sell Signal: Is Nurix Therapeutics Inc. stock a defensive play in 2025 - Улправда
Why Nurix Therapeutics Inc. stock appeals to analysts2025 Market Overview & Pattern Based Trade Signal System - ulpravda.ru
Nurix Therapeutics Chief Legal Officer Sells Shares - TradingView — Track All Markets
Officer Ring Sells 3,760 ($67.3K) Of Nurix Therapeutics Inc [NRIX] - TradingView — Track All Markets
Nurix Therapeutics (NRIX) Chief Legal Officer reports option exercise and stock sales - Stock Titan
Why Nurix Therapeutics Inc. stock could outperform in 2025Trade Risk Assessment & Stepwise Swing Trade Plans - Улправда
Institution Moves: Why Nurix Therapeutics Inc. stock appeals to analystsMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - Улправда
Nurix Therapeutics (NASDAQ:NRIX) Trading Down 4%Here's What Happened - MarketBeat
Nurix Therapeutics Advances Study for NX-5948 in CLL and SLL Patients - TipRanks
Nurix Therapeutics (NRIX) Receives a Buy from Wells Fargo - The Globe and Mail
Wells Fargo Raises Price Target for Nurix Therapeutics (NRIX) to $30 | NRIX Stock News - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Given New $30.00 Price Target at Wells Fargo & Company - MarketBeat
Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025 - ts2.tech
Nurix Therapeutics, Inc. $NRIX Shares Purchased by Nikko Asset Management Americas Inc. - MarketBeat
Redmile Group LLC Lowers Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Optimistic Investors Push Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Up 48% But Growth Is Lacking - 富途牛牛
Nurix prices 24.5M shares at $10.21 in underwritten registered offering - MSN
Nurix Therapeutics price target raised to $31 from $28 at HC Wainwright - MSN
Cathie Wood Reduces Iridium Holdings While Adding Biotech Stock Nurix Therapeutics - parameter.io
Why Cathie Wood Just Sold Millions in Iridium and Bought This Biotech Stock - CoinCentral
Cathie Wood’s ARK sells Iridium stock, buys Nurix on Wednesday By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK sells Iridium stock, buys Nurix on Wednesday - Investing.com
What insider trading reveals about Nurix Therapeutics Inc stockMarket Activity Report & Risk Controlled Daily Plans - moha.gov.vn
HC Wainwright & Co. Maintains Nurix Therapeutics (NRIX) Buy Recommendation - Nasdaq
NRIX: Mizuho Raises Price Target, Maintains Outperform Rating | - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $30.00 at Mizuho - MarketBeat
Nurix stock price target raised to $31 from $28 at H.C. Wainwright - Investing.com UK
NRIX: HC Wainwright & Co. Raises Price Target for Nurix Therapeu - GuruFocus
Mizuho Adjusts Price Target on Nurix Therapeutics to $30 From $24, Maintains Outperform Rating - marketscreener.com
Mizuho raises Nurix stock price target to $30 on positive CLL data - Investing.com
BTIG Maintains Nurix Therapeutics (NRIX) Buy Recommendation - Nasdaq
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 5.4%Here's Why - MarketBeat
NRIX Analyst Rating Update: BTIG Raises Price Target | NRIX Stoc - GuruFocus
Nurix Therapeutics Inc (NRIX) 財務データ
収益
当期純利益
現金流量
EPS
Nurix Therapeutics Inc (NRIX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Ring Christine | Chief Legal Officer |
Dec 18 '25 |
Sale |
17.90 |
3,760 |
67,314 |
50,897 |
0.57%
大文字化:
|
ボリューム (24 時間):